Italian Medicines Agency Agenzia Italiana del Farmaco

AIFA, unjustified alarm on safety of AstraZeneca vaccine - AIFA, unjustified alarm on safety of AstraZeneca vaccine

Asset Publisher

AIFA, unjustified alarm on safety of AstraZeneca vaccine

The cases of death occurred after administration of the AstraZeneca vaccine only have a temporal link. No causality was demonstrated between the two events. The alarm on safety of the AstraZeneca vaccine is not justified.

AIFA underlines that pharmacovigilance activities continue both at national and European level in collaboration with EMA, by carefully monitoring any possible adverse effect related to vaccination.

AIFA strongly reassures citizens on safety of the AstraZeneca vaccine, with a view to optimal adherence to the ongoing vaccination campaign.


Published on: 14 March 2021

Asset Publisher

Related documents

Asset Publisher

Galleria

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

ABC della Ricerca Clinica - Perché la randomizzazione è essenziale?

Go to YouTube channel

go to beginning of content